Citigroup Lowers PT on Johnson & Johnson to $70

Symbols: JNJ
Tags: Citigroup
Share

Citigroup has lowered the price target on Johnson & Johnson (NYSE: JNJ) from $72 to $70 and maintains its Buy rating.


 
 
< Previous
Oppenheimer Upgrades Ariba to Outperform, $36 PT
Next >
Brean Murray Maintains Buy, Raises PT to $23 for Seagate Technology
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust